Oncotelic Therapeutics Inc.

10/08/2025 | Press release | Distributed by Public on 10/08/2025 06:44

Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Oncotelic Therapeutics Inc. published this content on October 08, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 08, 2025 at 12:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]